Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Total Operating Expense: ¥637 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920735 Jiangsu Deyuan Pharmaceutical Co Ltd BJSE:920735
97 GF Score
Price ¥26.66
GF Value ¥29.61
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Deyuan Pharmaceutical Co Total Operating Expense?

Jiangsu Deyuan Pharmaceutical Co BJSE:920735 97 Total Operating Expense is ¥637 Mil as of Jun. 2026. GuruFocus rates BJSE:920735 with a GF Score™ of 97/100 and a GF Value™ of ¥29.61 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense for the three months ended in Jun. 2026 was ¥152 Mil. Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥637 Mil.

Jiangsu Deyuan Pharmaceutical Co Total Operating Expense Related Terms

Jiangsu Deyuan Pharmaceutical Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Deyuan Pharmaceutical Co Total Operating Expense Chart

Jiangsu Deyuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 324.42 377.62 442.96 544.66 625.66

Jiangsu Deyuan Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.21 158.62 149.04 178.02 151.54
BJSE:920735
97GF Score
Jiangsu Deyuan Pharmaceutical Co Ltd BJSE:920735
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Deyuan Pharmaceutical Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥637 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ¥637 Mil mean?
Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) has a Total Operating Expense of ¥637 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors.
Is Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense too high?
Jiangsu Deyuan Pharmaceutical Co's current Total Operating Expense is ¥637 Mil. Overall, Jiangsu Deyuan Pharmaceutical Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense compare to ZTS?
Jiangsu Deyuan Pharmaceutical Co's Total Operating Expense of ¥637 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors. Jiangsu Deyuan Pharmaceutical Co's current Total Operating Expense is ¥637 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Deyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.61, compared to a current price of ¥26.66 — trading 10% below its estimated fair value. The current Total Operating Expense is ¥637 Mil. Jiangsu Deyuan Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Jiangsu Deyuan Pharmaceutical Co (BJSE:920735), the current Total Operating Expense is ¥637 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥26.66 is trading 10% below its estimated GF Value™ of ¥29.61. GuruFocus considers Jiangsu Deyuan Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920735:

  • Total Operating Expense: ¥637 Mil
  • GF Value™: ¥29.61 vs. price of ¥26.66 (10% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Deyuan Pharmaceutical Co Business Description

Address No. 29, Changjiang Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222047
Jiangsu Deyuan Pharmaceutical Co Ltd is involved in research and development, production and sales of tablets, hard capsules, and raw materials.
97GF Score

Get the complete analysis for BJSE:920735

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.66
Price
¥29.61
GF Value